DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20213526

Programmatic evaluation of a school-based typhoid vaccination campaign: findings of qualitative research

Farhana Tabassum, Shanila Nooruddin, Atif Habib, Noshad Ali, Imtiaz Hussain, Alfred Pach, Zahid Memon, Sajid Soofi, Zulfiqar A. Bhutta

Abstract


Background: Globally, typhoid fever is a vaccine preventable infectious disease with significant morbidity and mortality. Apart from expanded program on immunization center, other alternative and accessible venues were needed for this vaccine like schools. The purpose of this study was to identify the factors influencing acceptance and rejection of participation in school-based typhoid vaccination program in target communities in Karachi.

Methods: A qualitative study was conducted, 46 in-depth interviews were conducted with parents, teachers and administrators in the schools where the typhoid vaccine was provided. NVivo was utilized for data coding and themes were derived along with WHO’s analytical framework, vaccine hesitancy, that is, confidence, convenience and complacency, in responses to the vaccination.

Results: Participants described confidence as a key factor that largely rooted their perceptions and attitudes related to the vaccination program. Stakeholders showed their concerns about affordability, safety and effectiveness and convenience of the vaccine’s delivery to the students. Satisfied participants from the school-based program showed lack of trust in quality of vaccine and vaccination procedures.

Conclusions: Our findings indicate the importance of providing adequate information on vaccination through multiple communication channels, sustained social mobilization programs including community engagement. Addressing concerns through dialogic interactions were crucial for motivation and acceptance of the vaccination program.


Keywords


School, Typhoid vaccine, Vaccination campaign

Full Text:

PDF

References


Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med. 2002;347(22):1770-82.

DeRoeck W, Maes C. Symmetries of the ratchet current. Phys Rev E Stat Nonlin Soft Matter Phys. 2007;76:051117.

Pang T, Bhutta ZA, Finlay BB, Altwegg M. Typhoid fever and other salmonellosis: a continuing challenge. Trends Microbiol. 1995;3(7):253-5.

Yang HH, Kilgore PE, Yang LH, Park JK, Pan YF, Kim Y, et al. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. J Infect Dis. 2001;183(12):1775-80.

Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, et al. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China. Bull World Health Organ. 2001;79(7):625-31.

Siddiqui FJ, Haider SR, Bhutta ZA. Risk factors for typhoid fever in children in squatter settlements of Karachi: a nested case-control study. J Infect Public Health. 2008;1(2):113-20.

Sinha ASS, Kumar R, Sood S, Reddaiah VP, Singh B, Rao M, et al. Typhoid fever in children aged less than 5 years. 1999;354(9180):734-7.

Lin FY, Vo AH, Phan VB, Nguyen TT, Bryla D, Tran CT, et al. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg. 2000;62(5):644-8.

Ochiai RL, Acosta CJ, Danovaro-Holliday M, Baiqing D, Bhattacharya SK, Agtini MD, et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ. 2008;86(4):260-8.

Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82(5):346-53.

Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet. 1990;336(8720):891-4.

Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med. 1987;317(18):1101-4.

Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 1987;2(8569):1165-9.

Klugman KP, Koornhof HJ, Robbins JB, LeCam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine. 1996;14(5):435-8.

Simanjuntak CH, Paleologo FP, Punjabi NH, Darmowigoto R, Soeprawoto, Totosudirjo H, et al. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet. 1991;338(8774):1055-9.

Organization WH. Everybody's business--strengthening health systems to improve health outcomes: WHO's framework for action. 2007. Available at: https://www.who.int/healthsyste ms/strategy/everybodys_business.pdf. Accessed on 3 March 2021.

Brotherton J, Pitcher H, Passaris I, Deeks S, Webby R, Campbell-Lloyd S, et al. Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia. Communicable Dis Intellig Quarter Rep. 2008;32(4):457.

Cabezas C, Echevarria C, Gomez G, Gotuzzo E. Pilot program of immunization against viral hepatitis B, integrated in the extended immunization program in Abancay (Peru). Revista De Gastroenterologia Del Peru. 1994;15(3):215-22.

Levine MM, Ferreccio C, Black RE, Germanier R. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet. 1987;1(8541):1049-52.

Edwards KM, Hackell JM, Diseases CI, Practice C, Medicine A. Countering vaccine hesitancy. Pediatrics. 2016;138(3):20162146.

Lahariya C, Khandekar J, Vachher A, Pradhan S. Physicians and communities knowledge and awareness about new vaccines in immunization program: a study to derive lesson for increasing uptake. Kathmandu Univ Med J. 2010;8(1):51-6.

Barbour RS. Checklists for improving rigour in qualitative research: a case of the tail wagging the dog? BMJ. 2001;322(7294):1115-7.

Coffey A, Atkinson P. Making sense of qualitative data: complementary research strategies. 1st ed. Sage Publications Inc; 1996.

Crawford HK, Leybourne ML, Arnott A. How we ensured rigor from a multi-site, multi-discipline, multi-researcher study. FQS. 2000.

Khan MI, Ochiai RL, Hamza HB, Sahito SM, Habib MA, Soofi SB, et al. Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial. Trials. 2006;7(1):17.

Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. Addressing the vaccine confidence gap. Lancet. 2011;378(9790):526-35.

DeRoeck D, Clemens JD, Nyamete A, Mahoney RT. Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in Asia. Vaccine. 2005;23(21):2762-74.

Siddiqui FJ, Rabbani F, Hasan R, Nizami SQ, Bhutta ZA. Typhoid fever in children: some epidemiological considerations from Karachi, Pakistan. Int J Infect Dis. 2006;10(3):215-22.

Soofi SB, Haq I, Khan MI, Siddiqui MB, Mirani M, Tahir R, et al. Schools as potential vaccination venue for vaccines outside regular EPI schedule: results from a school census in Pakistan. BMC Res Note. 2012;5(1):6.

Khan M, Bajracharya D, Pach US, Sahastrabuddhe S. Factors associated participation in a school based typhoid vaccination campaign in Nepal. J Vaccines Res Vaccin. 2016;2(4).

Impicciatore P, Bosetti C, Schiavio S, Pandolfini C, Bonati M. Mothers as active partners in the prevention of childhood diseases: maternal factors related to immunization status of preschool children in Italy. Prevent Med. 2000;31(1):49-55.

Baumgaertner B, Carlisle JE, Justwan F. The influence of political ideology and trust on willingness to vaccinate. PloS One. 2018;13(1):0191728.